SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: SARM1 NADase Inhibition Therapy

idea 1,497 words KG: SARM1 2026-03-24

kind:idea kind:therapy-idea section:ideas state:published

Contents

SARM1 NADase Inhibition Therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65

CYP46A1 Overexpression Gene Therapy
Score: 0.63 PARP1 Inhibition Therapy
Score: 0.58 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 HDAC3-Selective Inhibition for Clock Reset
Score: 0.46 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 R-Loop Resolution Enhancement Therapy
Score: 0.43 Low Complexity Domain Cross-Linking Inhibition
Score: 0.42 Glial Glycocalyx Remodeling Therapy
Score: 0.41 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39 Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39 Synaptic Vesicle Tau Capture Inhibition
Score: 0.34

Related Analyses (18)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (6)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40 Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40

Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40

See Also (9)

MAPK Signaling Pathways in Neurodegeneration
mechanism · KG edge: activates Alzheimer Indonesia
institution · KG edge: activates BAX Gene
gene · KG edge: activates nad-augmentation-therapy-early-ad
general · KG edge: activates Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: activates

Apoptosis in Neurodegeneration
entity · KG edge: activates Neurodegeneration
disease · KG edge: activates Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: activates blarcamesine-axon
clinical_trial · KG edge: activates

Knowledge Graph (12 edges)

SARM1 activates DLK

SARM1 activates PUMA

SARM1 activates Ms

SARM1 activates Apoptosis

SARM1 activates Mapk

SARM1 activates GBM

SARM1 therapeutic_target GLIOBLASTOMA

SARM1 therapeutic_target CANCER

SARM1 activates Tumor

SARM1 therapeutic_target Glioma

SciDEX — scidex.ai — Dashboard | Atlas